Casa
kit lamine sci

Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy: Molecular Therapy - Oncolytics

Di uno scrittore di uomini misteriosi

Descrizione
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy: Molecular Therapy - Oncolytics
Strategies targeting PD-L1 expression and associated opportunities for cancer combination therapy
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy: Molecular Therapy - Oncolytics
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy, Molecular Cancer
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy: Molecular Therapy - Oncolytics
Harnessing novel strategies and cell types to overcome immune tolerance during adoptive cell therapy in cancer
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy: Molecular Therapy - Oncolytics
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte -based adoptive T cell therapy: Molecular Therapy - Oncolytics
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy: Molecular Therapy - Oncolytics
Issue: Molecular Therapy - Oncolytics
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy: Molecular Therapy - Oncolytics
Engineering chimeric antigen receptor T cells for solid tumour therapy - Liu - 2022 - Clinical and Translational Medicine - Wiley Online Library
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy: Molecular Therapy - Oncolytics
IJMS, Free Full-Text
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy: Molecular Therapy - Oncolytics
News: PD-1 Targeted Cancer Immunotherapy Meets CRISPR - CRISPR Medicine
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy: Molecular Therapy - Oncolytics
Frontiers Emerging Strategies in TCR-Engineered T Cells
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy: Molecular Therapy - Oncolytics
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy, Molecular Cancer
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy: Molecular Therapy - Oncolytics
CRISPR/Cas9 encouraged CAR-T cell immunotherapy reporting efficient and safe clinical results towards cancer - ScienceDirect
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy: Molecular Therapy - Oncolytics
Immuno, Free Full-Text
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy: Molecular Therapy - Oncolytics
Frontiers Chimeric Antigen Receptor-T Cells: A Pharmaceutical Scope
da per adulto (il prezzo varia in base alle dimensioni del gruppo)